How much will the patient pay out of pocket after imatinib is included in medical insurance?

Imatinib/Gleevec (Imatinib), as an important drug for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST), has been included in the Chinese Medical Insurance List. With the continuous adjustment of medical insurance policies, the medical insurance coverage of imatinib has gradually expanded, and eligible patients can enjoy medical insurance reimbursement. This will undoubtedly help many patients with heavy financial burdens and reduce the pressure of drug costs.

In the Chinese market, the price of imatinib is relatively high. The common packaging specification is100mg*60 tablets, and the price per box is about RMB 2,000. Since drug prices may fluctuate depending on regions, sales channels, and market supply and demand, patients should consult their local hospital pharmacy to learn about the latest drug prices before purchasing.

After imatinib was included in the medical insurance, the patient’s out-of-pocket expenses were also effectively reduced. Depending on different regions and medical insurance policies, medical insurance can usually reimburse 60% to 80% of the cost. Therefore, in the case of medical insurance reimbursement, the specific amount of the patient's out-of-pocket portion will vary according to the medical insurance reimbursement ratio and conditions in the patient's region.

It should be noted that not all patients can enjoy reimbursement from medical insurance. Only patients who meet the indications and receive treatment according to the doctor's recommendations are eligible for medical insurance reimbursement. In addition, some patients may be required to provide relevant medical records and proof of treatment in order to qualify for medical insurance reimbursement. Therefore, before starting treatment, consult your doctor to find out whether you are eligible for medical insurance reimbursement and ensure that the cost of treatment can be reasonably supported.

In general, after imatinib was included in medical insurance, patients' out-of-pocket costs were effectively alleviated. Depending on your own financial situation and treatment needs, you can choose original drugs or generic drugs. Generic drugs are usually more affordable and are an ideal choice for many patients with tight financial conditions.

Reference materials:https://www.gleevec.com/